Drug profile · INN
inotuzumab ozogamicin
BESPONSA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
inotuzumab ozogamicin (BESPONSA) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
INN inotuzumab ozogamicin
Brand BESPONSA
Formulation POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER
ATC code L01FB01
Frequently asked questions
What is inotuzumab ozogamicin?
inotuzumab ozogamicin (BESPONSA) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for inotuzumab ozogamicin?
BESPONSA is a marketed brand name for inotuzumab ozogamicin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of inotuzumab ozogamicin?
inotuzumab ozogamicin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.